Safety Information and Side Effects

In clinical studies, IWILFIN was well-tolerated, and side effects were manageable.

  • 12% of patients who received IWILFIN reported new or worsening hearing loss, which was sometimes reversible by adjusting IWILFIN dosage 
  • The most common side effects of IWILFIN were hearing loss, vomiting, diarrhea, anemia, and dehydration 

Based on the severity of adverse reactions to IWILFIN, patients may reduce or stop their dose until the reaction subsides and the original dosage schedule can be restarted.